Charles Schwab’s Sagimet Biosciences SGMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$114K Hold
15,000
﹤0.01% 3410
2025
Q1
$48.9K Buy
+15,000
New +$48.9K ﹤0.01% 3405
2024
Q2
Sell
-51,869
Closed -$281K 3674
2024
Q1
$281K Buy
51,869
+39,307
+313% +$213K ﹤0.01% 3187
2023
Q4
$68.1K Hold
12,562
﹤0.01% 3372
2023
Q3
$111K Buy
+12,562
New +$111K ﹤0.01% 3342